Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
+0.11 (+0.67%)
as of 15:07 EST

U.S. Food and Drug Administration Accepts Karyopharm's

GlobeNewswire via COMTEX - 08:00AM EST
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its supplemental New Drug Application (sNDA) seeking (full story)
KPTI: 16.45 (+0.11)

Karyopharm to Participate at 9th Annual SVB Leerink

GlobeNewswire via COMTEX - Tue Feb 18, 07:00AM EST
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will participate in a fireside chat at the 9 Annual SVB Leerink Globa(full story)
KPTI: 16.45 (+0.11)

Karyopharm Thera Falls 2.26% on Heavy Volume: Watch

Comtex SmarTrend(R) via COMTEX - Thu Feb 13, 12:47PM EST
Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $16.05 to a high of $17.00. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $16.73 on volume of 355,000 s(full story)
KPTI: 16.45 (+0.11)

Karyopharm Reports Fourth Quarter and Full Year 2019

GlobeNewswire via COMTEX - Thu Feb 13, 07:00AM EST
-- XPOVIO Net Product Sales of $17.7 Million for Fourth Quarter and $30.5 Million for Full Year 2019 --(full story)
KPTI: 16.45 (+0.11)

Karyopharm and Promedico, a Member of the Neopharm

GlobeNewswire via COMTEX - Tue Feb 11, 07:00AM EST
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, and Promedico, a member of the Neopharm Group, today announced their entry into an exclusive distribution agreement for the commercialization (full story)
KPTI: 16.45 (+0.11)